Tootfinder

Opt-in global Mastodon full text search. Join the index!

@curiouscat@fosstodon.org
2026-02-24 16:28:53

"GiveWell has long recognized the potential for highly cost-effective vaccine programs. We started supporting #vaccination programs in 2015 and have made over $200 million in vaccination-related grants to date. For example, New Incentives, one of our Top Charities, aims to increase routine childhood vaccinations in northern Nigeria by providing small cash incentives to caregivers who brin…

Podcast Episode 24: Testing New Strategies to Increase Vaccination Coverage - The GiveWell Blog
In this episode, GiveWell CEO and co-founder Elie Hassenfeld speaks with Natalie Crispin about how our research approach has evolved and what it means for helping more children access life-saving vaccinations.

@cdarwin@c.im
2026-03-04 17:56:32

Monoclonal antibody therapies are being developed to treat #measles in response to its recent resurgence.
David A Kennedy argues that such therapies risk driving measles virus evolution in ways that might undermine the protection offered by #vaccination.

Developing monoclonal antibody therapies for measles could lead to adverse pathogen evolution
Monoclonal antibody therapies are being developed to treat measles in response to its recent resurgence. This Perspective argues that such therapies risk driving measles virus evolution in ways that might undermine the protection offered by vaccination.